TABLE 1.
Clinical characteristics of the patients with Parkinson’s disease (PD) and healthy controls (HC).
HC (n = 40) |
PD
|
|||
Early (n = 24) | Advanced (n = 18) | Total (n = 42) | ||
Sex (female/male) | 19/21 | 9/15 | 8/10 | 17/25 |
Age (years) | 65.85 ± 7.52 | 61.58 ± 9.57 | 71.61 ± 9.15 | 65.88 ± 10.55 |
Duration (years) | 5.78 ± 4.94 | 13.06 ± 6.58 | 8.88 ± 6.69 | |
Hoehn and Yahr stage | 1.54 ± 0.51 | 3.22 ± 0.43 | 2.17 ± 0.93 | |
LEDD (mg) | 549.73 ± 548.88 | 1422.69 ± 662.50 | 923.86 ± 736.32 | |
UPDRS-total | 23.38 ± 6.53 | 69.29 ± 21.71 | 42.37 ± 27.15 | |
UPDRS-part III | 13.92 ± 5.40 | 40.36 ± 12.54 | 24.88 ± 15.93 | |
MMSE | 29.62 ± 0.72 | 28.33 ± 2.76 | 22.59 ± 6.48 | 25.95 ± 5.42 |
CDR | 0.13 ± 0.22 | 0.27 ± 0.25 | 0.59 ± 0.40 | 0.41 ± 0.36 |